Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain

DSpace Repository

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain

Author: Roitbergt, F.; Amaralt, T.; Cherny, N. I.; Giuliani, R.; Latino, N. J.; Galotti, M.; Bricalli, G.; Curigliano, G.; Pentheroudakis, G.; Trapani, D.
Tübinger Autor(en):
Amaralt, Teresa
Published in: Esmo Open (2023), Bd. 8 (5), Article 101617
Verlagsangabe: Amsterdam : Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.esmoop.2023.101617
ISSN: 2059-7029
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)